Center for the Biology of Chronic Disease (CBCD)

Parkinson's Disease May Be Caused by EBV; the CBCD Reviews the Medical Evidence

A study supported the role of the Epstein-Barr virus in the development of Parkinson's Disease. (1)


Rochester, NY -- (SBWIRE) -- 08/31/2015 -- "Infected with the Epstein Barr Virus (EBV)? The CBCD recommends taking Gene-Eden-VIR or Novirin." - Greg Bennett, CBCD

A study showed that the Epstein Barr Virus (EBV), which normally causes infectious mononucleosis (the kissing disease), and which has been linked to numerous forms of cancer, may also cause Parkinson's Disease (PD). Dr. X.L. Bu and colleagues wrote that there was a "Higher infectious burden was found in PD patients … (and) ... individuals with higher infectious burden had higher alpha-synuclein levels in serum." (1) Dr. Bu is from the Department of Neurology and Center for Clinical Neuroscience at the Daping Hospital in China. The study supported a role for EBV in the etiology (the cause or origin) of PD.

The CDC notes that "Epstein-Barr Virus (EBV), also known as human herpesvirus 4, is a member of the herpes virus family. It is one of the most common human viruses. EBV is found all over the world. Most people get infected with EBV at some point in their lives." (2) The Center for the Biology of Chronic Disease (CBCD) recommends that in light of the medical evidence, infected individuals take Gene-Eden-VIR or Novirin. The formula of these natural, antiviral supplements was designed to help the immune system target the latent EBV.

Click to learn more about EBV symptoms.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the formula is effective against the herpes family of viruses. The Epstein Barr Virus (EBV) is a member of the herpes family. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with the EBV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR." (3) The study authors also wrote that, "We observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (3)

Gene-Eden-VIR and Novirin can be ordered on their product websites, here:

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims. Note: Novirin has the same formula as Gene-Eden-VIR. However, it contains higher quality and more expensive ingredients.

Authors of another study wrote that "synuclein aggregation in Parkinson's disease (may be) is an Epstein-Barr virus (EBV)-induced autoimmune phenomenon … further support for an EBV-induced immune pathogenesis for Parkinson's disease could have profound therapeutic implications. " (4)

What treatments are available for EBV infections?

"A few antiviral drugs are available that were shown to inhibit EBV replication in cell culture. These drugs include the acyclic nucleoside analogues aciclovir, ganciclovir, penciclovir, and their respective prodrugs valaciclovir, valganciclovir and famciclovir, the acyclic nucleotide analogues cidofovir and adefovir, and the pyrophosphate analogue foscarnet. However, clinical studies have shown that these drugs are mostly ineffective in humans." (3) There are also natural antiviral products that studies show to be safe and effective in reducing EBV symptoms. Two of these products are Novirin and Gene-Eden-VIR.

"Based on the results of these studies, and the CBCD's own research, we recommend that EBV infected individuals take Gene-Eden-VIR or Novirin." - Greg Bennett, CBCD

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.


(1) Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, Liu CH, Deng B, Yao XQ, Xu ZQ, Zhou HD, Wang YJ. The association between infectious burden and Parkinson's disease: A case-control study. Parkinsonism Related Disorders, pii: S353-800(5)0033-3. Online first, 05 May 30.

(2) - About Epstein-Barr Virus (EBV). Last updated January 6, 2014

(3) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.

(4) John M. Woulfe, Madison T. Gray, Douglas A. Gray, David G. Munoz, Jaap M. Middeldorp "Hypothesis: A role for EBV-induced molecular mimicry in Parkinson's disease" Published Online: March 25, 2014